CIK 0001382101
- Non-accelerated filer
- Smaller reporting company
SUTRO BIOPHARMA, INC.
Sign in to watch- Ticker
- STRO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 452441988
- Phone
- +1 650-392-8412
- Business address
- 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Former names
- SUTRO BIOPHARMA INC, Fundamental Applied Biology Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-01 | Srinivasan Venkatesh Chief Tech Op Officer | Grant or award · Restricted Stock Unit (RSU) | +10,000 | 10,000 | ||
| 2023-04-14 | Hallam Trevor Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion | +3,750 | 101,664 | ||
| 2023-04-14 | Hallam Trevor Pres. Rsrch & Cf. Sctific Ofcr | Shares withheld for taxes | −1,296 | $4.40 | $6K | 100,368 |
| 2023-04-14 | Hallam Trevor Pres. Rsrch & Cf. Sctific Ofcr | Exercise or conversion · Restricted Stock Unit (RSU) | −3,750 | 7,500 | ||
| 2023-03-15 | Borgman Anne Elizabeth Chief Medical Officer | Grant or award · Stock Option (right to buy Common Stock) | +175,000 | 175,000 | ||
| 2023-03-15 | Borgman Anne Elizabeth Chief Medical Officer | Grant or award · Restricted Stock Unit (RSU) | +150,000 | 150,000 | ||
| 2023-03-03 | Shtylla Brunilda Chief Business Officer | Exercise or conversion | +6,750 | 24,702 | ||
| 2023-03-03 | Shtylla Brunilda Chief Business Officer | Exercise or conversion | +4,375 | 29,077 | ||
| 2023-03-03 | Shtylla Brunilda Chief Business Officer | Shares withheld for taxes | −4,536 | $5.79 | $26K | 25,541 |
| 2023-03-03 | Shtylla Brunilda Chief Business Officer | Grant or award · Stock Option (right to buy Common Stock) | +40,000 | 40,000 | ||
| 2023-03-03 | Shtylla Brunilda Chief Business Officer | Grant or award · Restricted Stock Unit (RSU) | +27,500 | 27,500 | ||
| 2023-03-03 | Shtylla Brunilda Chief Business Officer | Exercise or conversion · Restricted Stock Unit (RSU) | −6,750 | 20,250 | ||
| 2023-03-03 | Shtylla Brunilda Chief Business Officer | Exercise or conversion · Restricted Stock Unit (RSU) | −4,375 | 8,750 | ||
| 2023-03-03 | NEWELL WILLIAM J CEO | Exercise or conversion | +31,125 | 163,312 | ||
| 2023-03-03 | NEWELL WILLIAM J CEO | Exercise or conversion | +18,750 | 182,062 | ||
| 2023-03-03 | NEWELL WILLIAM J CEO | Shares withheld for taxes | −17,246 | $5.79 | $100K | 164,816 |
| 2023-03-03 | NEWELL WILLIAM J CEO | Grant or award · Stock Option (right to buy Common Stock) | +125,000 | 125,000 | ||
| 2023-03-03 | NEWELL WILLIAM J CEO | Grant or award · Restricted Stock Unit (RSU) | +95,000 | 95,000 | ||
| 2023-03-03 | NEWELL WILLIAM J CEO | Exercise or conversion · Restricted Stock Unit (RSU) | −31,125 | 93,375 | ||
| 2023-03-03 | NEWELL WILLIAM J CEO | Exercise or conversion · Restricted Stock Unit (RSU) | −18,750 | 37,500 |
Page 16 of 27 · 535 trades